Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Jiangyi Yu"'
Autor:
Jing Sun, Run Shi, Yang Wu, Yan Lou, Lijuan Nie, Chun Zhang, Yutian Cao, Qianhua Yan, Lifang Ye, Shu Zhang, Xuanbin Wang, Qibiao Wu, Xuehua Jiao, Jiangyi Yu, Zhuyuan Fang, Xiqiao Zhou
Publikováno v:
Journal of Big Data, Vol 11, Iss 1, Pp 1-20 (2024)
Abstract Background Nonalcoholic fatty liver disease (NAFLD) is a leading public health problem worldwide. Approximately one fourth of patients with nonalcoholic fatty liver (NAFL) progress to nonalcoholic steatohepatitis (NASH), an advanced stage of
Externí odkaz:
https://doaj.org/article/f4b20cf2d4fd499bbeb70dd5d7c701a6
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectiveThis study sought to elucidate the causal association between gut microbiota (GM) composition and type 2 diabetes mellitus (T2DM) through a comprehensive two-sample bidirectional Mendelian randomization analysis.MethodT2DM data were sourced
Externí odkaz:
https://doaj.org/article/6d1955fc0f7b4f53839f4ce91cc336ac
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Background: Diabetic kidney disease (DKD) is one of the most serious microvascular complications of diabetes, with the incidence rate increasing yearly, which is the leading cause of chronic kidney disease (CKD) and end-stage kidney disease. Abelmosc
Externí odkaz:
https://doaj.org/article/8b60d8377efd4122aa6e770dc7d06ff9
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/5e6c3c69a39f43d6b6eab68e790c2135
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/9c6cb58e9e57413ca798a23c760e51d8
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundThe diversity of clinical trajectories in diabetic kidney disease (DKD) has made blood and biochemical urine markers less precise, while renal puncture, the gold standard, is almost impossible in the assessment of diabetic kidney disease, a
Externí odkaz:
https://doaj.org/article/449354217f954421a2ee51c6949877f0
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundGlucagon-like peptide-1 receptor agonists (GLP-1RAs) significantly reduce postprandial blood glucose, inhibit appetite, and delay gastrointestinal emptying. However, it is controversial that some patients are intolerant to GLP-1RAs.MethodsP
Externí odkaz:
https://doaj.org/article/de72112a0ed64712b4cfcf8a673ed9bd
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ObjectiveWe aimed to explore the value of Huobahuagen tablet (HBT) in improving decreased renal function for patients with diabetic kidney disease (DKD) over time.MethodsThis was a single-center, retrospective, real-world study on eligible 122 DKD pa
Externí odkaz:
https://doaj.org/article/842b210408af401c807a91ba507e1abd
Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: A systematic review and meta-analysis
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ObjectiveClinical trials have shown that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are closely associated with hepatic fibrosis and steatosis by FibroScan. This paper aimed at evaluating the effects of SGLT2i on hepatic fibrosis and steatosi
Externí odkaz:
https://doaj.org/article/020368691f774301bb62ff3216c3ff41
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 3, Pp 525-531 (2022)
Abstract Aims/Introduction In this paper, we focused on exploring the diagnostic and predictive clinical utility of ankle‐brachial index (ABI) in combination with feet electrochemical skin conductance (FESC) for peripheral artery disease (PAD) in C
Externí odkaz:
https://doaj.org/article/80f04cc99b324f17a5e710d67a5830c3